New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 12, 2014
10:07 EDTVALE, LEAF, THRX, SFUN, LULU, STO, AXS, MONT, HA, CHSP, AAUKY, DLAKY, DTV, CEVA, AFLYY, RRMS, HIMX, CPSI, BRGYYOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: AXIS Capital (AXS) downgraded to Sell from Neutral at Goldman... Air France-KLM (AFLYY) downgraded to Underperform from Hold at Jefferies... Anglo American (AAUKY) downgraded to Underweight from Equal Weight at Morgan Stanley... Associated Estates (aec) downgraded to Sell from Neutral at Citigroup... BG Group (BRGYY) downgraded to Neutral from Buy at Nomura... CEVA (CEVA) downgraded to Sell from Neutral at Chardan... Chesapeake Lodging (CHSP) downgraded to Market Perform from Outperform at FBR Capital... Computer Programs (CPSI) downgraded to Underweight from Hold at KeyBanc... DirecTV (DTV) downgraded to Neutral from Outperform at Macquarie... Hawaiian Holdings (HA) downgraded to In-Line from Outperform at Imperial Capital... Himax (HIMX) downgraded to Hold from Buy at Craig-Hallum... Lufthansa (DLAKY) downgraded to Hold from Buy at Jefferies... Montage Technology (MONT) downgraded to Hold from Buy at Needham... Rose Rock Midstream (RRMS) downgraded to Neutral from Outperform at RW Baird... SouFun (SFUN) downgraded to Hold from Buy at Deutsche Bank... Springleaf (LEAF) downgraded at Sterne Agee... Statoil (STO) downgraded to Hold from Buy at Deutsche Bank... Theravance (THRX) downgraded at Stifel... Vale (VALE) downgraded at Morgan Stanley... lululemon (LULU) downgraded to Hold from Buy at Stifel.
News For AXS;AFLYY;AAUKY;BRGYY;CEVA;CHSP;CPSI;DTV;HA;HIMX;DLAKY;MONT;RRMS;SFUN;LEAF;STO;THRX;VALE;LULU From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
April 17, 2015
06:17 EDTDTVVerizon to offer monthly custom TV plans, Reuters reports
Subscribe for More Information
April 16, 2015
19:48 EDTAAUKYAnglo American weighs syndication of Quellaveco project, Reuters says
Subscribe for More Information
10:00 EDTCEVAOn The Fly: Analyst Initiation Summary
Subscribe for More Information
10:00 EDTAAUKYOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: AGCO (AGCO) downgraded to Underweight from Neutral at JPMorgan... Alcatel-Lucent (ALU) downgraded to Buy from Conviction Buy at Goldman... Anglo American (AAUKY) downgraded to Sell from Neutral at Goldman... BAE Systems (BAESY) downgraded to Neutral from Buy at UBS... BHP Billiton (BHP) downgraded to Neutral from Conviction Buy at Goldman... Black Diamond (BDE) downgraded on valuation at Stifel... Boston Private Financial (BPFH) downgraded to Hold from Buy at Sandler O'Neill... Columbus McKinnon (CMCO) downgraded to Neutral from Buy at CL King... CoreSite Realty (COR) downgraded to Hold from Buy at Evercore ISI... Meggitt (MEGGF) downgraded to Sell from Neutral at UBS... Methanex (MEOH) downgraded to Sector Perform from Outperform at Scotia Capital... Nokia (NOK) downgraded to Neutral from Buy at Citigroup... SanDisk (SNDK) downgraded to Sell from Neutral at BTIG... Thomson Reuters (TRI) downgraded to Sector Perform from Outperform at RBC Capital... Turquoise Hill (TRQ) downgraded to Hold from Speculative Buy at TD Securities... Washington Federal (WAFD) downgraded to Neutral from Buy at DA Davidson.
08:15 EDTTHRXGlaxoSmithKline and Theravance announce launch of Anoro in Spain
In a regulatory filing, GlaxoSmithKline (GSK) and Theravance (THRX) announced the launch of Anoro in Spain following the approval in Europe in May 2014. Anoro Ellipta is indicated as a once-daily maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease. Anoro Ellipta is a combination of two bronchodilators, umeclidinium, a long-acting muscarinic antagonist and vilanterol, a long-acting beta2 agonist, in a single dry powder inhaler, the Ellipta. The approved dose of UMEC/VI is 55/22mcg. UMEC/VI has been developed under the 2002 LABA collaboration agreement between Glaxo Group Limited and Theravance.
06:48 EDTCEVACEVA initiated with a Buy at Canaccord
Target $27.
05:46 EDTAAUKYAnglo American downgraded to Sell from Neutral at Goldman
Subscribe for More Information
April 15, 2015
14:58 EDTLEAFEarnings Watch: Analysts more bullish on Citi after asset sales, CCAR approval
Citigroup (C), one of the largest banks in the U.S., is expected to report first quarter earnings before the open on Thursday, April 16, with a conference call scheduled for 11:00 am ET. EXPECTATIONS: Analysts are looking for earnings per share of $1.39 on revenue of $19.82B. The consensus range is $1.32-$1.45 for EPS on revenue of $18.43B-$20.36B, according to First Call. On its last earnings conference call, Citi said it was committed to its 2015 targets and to returning capital to shareholders. Citi is targeting a 2015 consumer banking efficiency ratio of 49%-52%, compared to a ratio of 56% in 2014 and a pro forma 2014 ratio of 55%. LAST QUARTER: Citigroup reported fourth quarter EPS of 6c, versus analysts' consensus forecast of 11c. The company’s revenue came in below expectations at 17.81B. Citi CEO Michael Corbat said at the time: "While the overall results for 2014 fell short of our expectations, we did make significant progress on our top priorities... Although we made some difficult decisions over the course of the year, I believe they allowed us to put our franchise in a position to have a successful 2015." NEWS: On March 2, Costco (COST) announced it has entered into a new co-brand credit card program agreement with Citi and an acceptance and co-brand incentive agreement with Visa (V). Under the terms of the agreements, Citi would become the exclusive issuer of Costco's co-brand credit cards and Visa will replace American Express as the credit card network for Costco in the U.S. and Puerto Rico beginning April 1, 2016. The next day, Citi announced that it has reached a definitive agreement to sell OneMain Financial Holdings to Springleaf (LEAF) for a purchase price of $4.25B. The deal is expected to close in the third quarter of 2015, subject to approvals and other customary conditions. The sale, along with retirement of related funding, are expected to result in a net addition to earnings before income taxes of approximately $1B, the bank stated. On March 5, the Federal Reserve said that Citi had passed its Dodd-Frank stress test, as did all 31 banks that were examined. About a week later, the central bank announced it had not objected to the capital plans of 28 bank holding companies participating in the Comprehensive Capital Analysis and Review, or CCAR. After the Fed advised Citi that it has no objection to the planned capital actions requested by the bank, Citi said it will increase its quarterly common stock dividend to 5c per share from 1c per share. Citi also announced plans for a common stock repurchase program of up to $7.8B during the five quarters starting in the Q2. At the end of March, Citi announced that it has reached a definitive agreement to sell 100% of the shares of Citi Cards Japan, the exclusive issuer of Diners Club cards in Japan, to Sumitomo Mitsui Trust Bank. Also in March, Citi announced that it has sold 396M common shares in Akbank T.A.S. through an equity offering representing its entire 9.9% equity interest in the company. Total proceeds from the transaction are expected to be approximately $1.15B at then current exchange rates. The financial terms of those two transactions are not material to Citi, the bank noted. STREET RESEARCH: On February 10, Deutsche Bank upgraded Citi to Buy from Hold and raised its price target for shares to $54 from $51. Deutsche said then that it believed the decline in the stock since the firm's December 4 downgrade had priced in some of the earnings risk, but added the FY15 consensus estimates for Citi still looked too high. On March 17, Deutsche Bank further raised its price target for Citi shares to $56 from $54, citing positive news flow around the sale of OneMain, its credit card deal with Costco and the Fed's stress test results. On March 3, JPMorgan upgraded Citigroup to Overweight, saying the Costco co-branding credit card deal will add to revenue growth and return on assets. Further, the firm said it expects the banking giant to achieve its operating efficiency targets this year. It upped its price target for shares to $58 from $54. The next day, Morgan Stanley said it believes Citi's sale of OneMain and its new Costco partnership imply, when taken together, that the bank is substituting OneMain's higher risk assets with the Costco portfolio, which has a lower yield, risk and RWA. Such a trade will be viewed favorably by regulators, the firm said. Morgan Stanley, which has an Overweight rating on Citi, said then it sees potential upside to its $60 price target on Citi shares if capital freed from the OneMain sale is returned to shareholders. PRICE ACTION: In afternoon trading ahead of tomorrow morning's report, Citi rose over 1% to $53.31. Over the last three months, Citi shares are up nearly 13%.
10:19 EDTDTVOptions with decreasing implied volatility
Subscribe for More Information
10:00 EDTVALEOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
07:53 EDTCPSITopeka Capital to hold events at HIMSS '15
Subscribe for More Information
06:47 EDTVALEVale downgraded to Neutral from Overweight at JPMorgan
Subscribe for More Information
April 14, 2015
19:02 EDTAXSAXIS Capital acknowledges Exor made unsolicited proposal for PartnerRe
Subscribe for More Information
12:24 EDTAXSOn The Fly: Top stock stories at midday
Stocks on Wall Street were mixed at midday despite better than expected headline earnings from JPMorgan (JPM), Wells Fargo (WFC) and Johnson & Johnson (JNJ). The market began the session in positive territory on the heels of those solid earnings reports, but the averages were unable to hold their early gains as the retail sales figures released during the pre-market trading session missed expectations. ECONOMIC EVENTS: In the U.S., retail purchases grew 0.9% in March, rebounding from a 0.5% decline in February. However, economists were expecting a more pronounced 1.1% advance in recovery from the prior month's weather driven weakness. The producer price index rose 0.2% in March, matching expectations. The core PPI, which excludes food and energy, grew 0.2% as well, versus expectations for it to have risen 0.1%. Business Inventories grew 0.3% in February, versus expectations for them to be up 0.2%. The International Monetary Fund, in its latest World Economic Outlook Report, trimmed its U.S. growth forecast to a 3.1% pace from its prior 3.6% view, but left its global forecast intact at a 3.5% rate. COMPANY NEWS: Shares of JPMorgan advanced 1.5% after its headline earnings per share topped expectations, even before accounting for 13c per share in aftertax legal expense that the bank identified as a "significant item." Conversely, fellow large bank Wells Fargo (WFC) slid 1.5% after its own report on first quarter results, despite the fact that its earnings and revenue both topped the consensus forecast... Shares of Johnson & Johnson (JNJ) were fractionally higher at midday after its first quarter earnings and revenue beat expectations. The multinational company, however, lowered its FY15 adjusted earnings outlook, citing further negative foreign currency movements... Nokia (NOK) and Alcatel-Lucent (ALU), in response to "recent media speculation," confirmed that they are in advanced discussions with respect to a potential full combination, which would take the form of a public exchange offer by Nokia for Alcatel. MAJOR MOVERS: Among the notable gainers was 58.com (WUBA), which jumped 25% after Financial Times reported the company has signed a memorandum of understanding to merge with peer Ganji.com to create one of the largest specialized online classified companies in China. Also higher was PartnerRe (PRE), which advanced nearly 9% to trade near $129.50 after Europe based investment company EXOR announced that it submitted a written proposal to acquire 100% of the common shares of the company for $130.00 per share in cash, valuing PartnerRe at $6.4B. EXOR said its all-cash proposal represents a 16% premium to the implied value per share of $112.53 for PartnerRe under the merger deal it has in place with AXIS Capital (AXS). Among the noteworthy losers was Arrowhead Research (ARWR), which tumbled over 6% after Jefferies downgraded the stock to Hold and cut its price target for shares to $9 from $30 after assuming coverage of the stock. The firm said that while ARC-520 offers the potential for a Hepatitis B virus functional cure, it prefers to wait for multi-dosing data. Also lower was Norfolk Southern (NSC), which fell nearly 6% and was downgraded to Hold from Buy at TD Securities after the railroad operator provided first quarter guidance that came in below analysts' consensus estimates. INDEXES: Near midday, the Dow was up 53.15, or 0.3%, to 18,030.19, the Nasdaq was down 16.19, or 0.32%, to 4,972.06, and the S&P 500 was up 2.20, or 0.11%, to 2,094.63.
11:55 EDTAXSEXOR tops AXIS offer with $130 per share bid for PartnerRe
Subscribe for More Information
10:34 EDTDTVOptions with decreasing implied volatility
Subscribe for More Information
April 13, 2015
10:00 EDTVALE, AAUKYOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:26 EDTVALEVale downgraded to Sell from Neutral at UBS
09:01 EDTCPSICPSI announces formation of Evident, LLC subsidiary
Subscribe for More Information
05:33 EDTAAUKYAnglo American downgraded to Sell from Neutral at Citigroup
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use